How Analysts Rate Harvest Health & Recreation after Its Earnings

By

Sep. 4 2020, Updated 7:54 a.m. ET

Harvest Health & Recreation

Harvest Health & Recreation (HRVSF) released its first-quarter earnings results on May 31. It generated revenue of $19.2 million in the quarter, a year-over-year rise of 131%. Its revenue rose 14% sequentially.

Harvest Health & Recreation reported an operational gross profit before biological assets accounting of $7.9 million, or 41% of its revenue. The same metric stood at $4.3 million, or 52% of its revenue, in the first quarter of 2018.

Cresco Labs also reported a fall in its gross profit margins in the first quarter.

Article continues below advertisement

First-quarter earnings

Meanwhile, Harvest Health & Recreation reported a loss on the EBITDA and net income fronts in the first quarter. It reported adjusted EBITDA of -$4.7 million in the quarter compared to $1.9 million in the first quarter of 2018. The company reported a net loss of $20 million in the first quarter compared to a net profit of $1.2 million in the first quarter of 2018. Incidentally, Harvest Health & Recreation’s first-quarter net loss exceeded its revenue. It attributed the loss to “planned investments in people and infrastructure to support the company’s growth initiatives and planned expansion.”

Analysts’ recommendations

Harvest Health & Recreation has received “strong buy” ratings from three analysts, while the remaining three analysts polled by Thomson Reuters on June 3 have given it “buy” or equivalent ratings. The stock has received a mean consensus price target of 19.2 Canadian dollars, which represents a potential upside of 125% over its closing price on June 3. There hasn’t been any major analyst action following Harvest Health & Recreation’s first-quarter earnings release. The company’s stock fell 22.8% in May, but it’s up 19.4% year-to-date.

Advertisement

More From Market Realist

  • Flora Growth logo and woman looking at marijuana plants
    Cannabis
    What to Expect From the Flora Growth IPO This Week
  • Trulieve and Harvest Health logos over marijuana
    Cannabis
    Trulieve Acquires Harvest Health in Multi-Billion Dollar Deal
  • Tilray logo over marijuana harvest
    Cannabis
    Is Tilray (TLRY) Stock a Good Buy? According to Jefferies, Yes
  • Marijuana plant
    Cannabis
    What the Tilray and Aphria Merger Means for Investors
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.